Advertisement

Topics

Blueprint Medicines’ Cancer Drug Impresses In Early Study

14:06 EDT 15 Apr 2018 | Forbes

"This is fantastic for a phase I study," says Vivek Subbiah, the M.D. Anderson researcher who ran the trial with funding from BluePrint, at a press conference. "I do a lot of phase I studies."

Original Article: Blueprint Medicines’ Cancer Drug Impresses In Early Study

NEXT ARTICLE

More From BioPortfolio on "Blueprint Medicines’ Cancer Drug Impresses In Early Study"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...